If You Invested in Globalink Invest (GLLI)
Looking for the live price? See the GLLI quote & overviewWhat $1,000 or $10,000 in GLLI Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Dec 23, 2021 |
|---|---|---|---|---|
| $1,000 | $255 -74% | — | — | $305 -70% |
| $10,000 | $2,553 -74% | — | — | $3,046 -70% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for GLLI$1,000 Investment Over Time
GLLI vs S&P 500Year-by-Year Returns
GLLI annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2021 | $9.85 | $9.82 | -0.3% | -0.3% |
| 2022 | $9.82 | $10.20 | +3.9% | +3.6% |
| 2023 | $10.20 | $10.84 | +6.3% | +10.1% |
| 2024 | $10.85 | $11.77 | +8.5% | +19.5% |
| 2025 | $11.77 | $3.00 | -74.5% | -69.5% |
About Globalink Invest
Blank Checks · OTC Link
Globalink Investment Inc. (GLLI) is a Delaware corporation in the financial services sector, classified among shell companies. According to its SEC filings, Globalink functions as a special purpose acquisition company (SPAC) that seeks to complete an initial business combination. Its structure and activities are focused on identifying and executing a merger or similar transaction rather than operating an ongoing commercial business.
Globalink is described in SEC documents as an emerging growth company under U.S. securities regulations. The company completed its initial public offering on December 9, 2021, and established a trust account for the benefit of its public stockholders. Funds in this trust are used in connection with the company’s efforts to consummate a business combination, subject to stockholder redemption rights and other conditions set out in its charter and transaction agreements.
Business combination with Alps Life Sciences Inc.
Globalink’s filings describe a Business Combination Agreement involving several parties: Alps Life Sciences Inc. (a Cayman Islands company referred to as Alps or Alps Holdco), Alps Global Holding Pubco (a Cayman Islands exempted company referred to as PubCo), and Alps Biosciences Merger Sub (a Cayman Islands exempted company and wholly owned subsidiary of PubCo). GL Sponsor LLC is identified as the Parent Representative, and an individual, Dr. Tham Seng Kong, is identified as the Seller Representative for the shareholders of Alps Holdco.
Under the Business Combination Agreement and related amendments, the proposed transaction is structured in two main steps. First, Globalink will merge with and into PubCo, with PubCo remaining as the surviving publicly traded entity in what the filings call the Redomestication Merger. Second, Alps Biosciences Merger Sub will merge with and into Alps, with Alps remaining as the surviving entity and becoming a wholly owned subsidiary of PubCo in what the filings call the Acquisition Merger. The combined effect is to place Alps under a publicly traded holding company structure, with PubCo as the listed entity.
Stockholder approvals and charter amendments
Globalink’s SEC filings report that a special meeting of stockholders was held on October 7, 2025, to vote on proposals related to the Business Combination Agreement. The filings state that stockholders approved the Redomestication Merger, the Acquisition Merger, and an amendment to Globalink’s charter. The charter amendment, described as a Net Tangible Asset Charter Amendment, removes a limitation that required Globalink or any successor to have net tangible assets of at least a specified amount upon consummation of its initial business combination.
The filings explain that the special meeting and related proxy materials were conducted under a registration statement on Form F-4 filed by PubCo with the U.S. Securities and Exchange Commission. That registration statement includes a proxy statement/prospectus used to solicit proxies from Globalink’s stockholders and to register the securities of PubCo to be issued in connection with the business combination.
Extensions of the business combination deadline
Globalink’s reports describe a series of extensions to the deadline by which it must complete its initial business combination. In an 8-K filing, the company states that on October 4, 2025, it deposited an extension payment into its trust account for public stockholders. This payment enabled Globalink to extend the period it has to consummate its initial business combination by one month, from October 9, 2025 to November 9, 2025, referred to as the Termination Date.
The same filing notes that this was the twenty-eighth extension since the consummation of Globalink’s initial public offering and the fifth of up to six extensions permitted under its Amended and Restated Certificate of Incorporation, as amended. These details highlight the SPAC structure, in which the company’s life and ability to complete a business combination are governed by its charter and by specified time limits that can be extended under defined conditions.
Redemptions of public shares
In connection with the special meeting and the stockholder votes on the business combination proposals, Globalink’s filings report that certain holders of its public shares exercised their right to redeem their shares for cash. After these redemptions, the filings state that a reduced number of public shares remained outstanding. This redemption mechanism is a standard feature of SPAC structures, allowing public stockholders to receive cash from the trust account instead of continuing as shareholders of the combined company after the business combination.
Regulatory filings and disclosure framework
Globalink’s SEC filings emphasize that the proposed transactions are subject to regulatory review and stockholder approval. The company and PubCo have filed a registration statement on Form F-4 with the SEC, which includes a proxy statement/prospectus and incorporates other relevant documents by reference. Stockholders are directed in the filings to review these materials carefully, as they contain detailed information about the proposed transactions, the parties involved, and associated risks.
The filings also include standard securities law disclosures, explaining that the documents are not themselves offers to sell or solicitations of offers to buy securities in jurisdictions where such offers or sales would be unlawful. They further note that investment in any securities described has not been approved or disapproved by the SEC or any other regulatory authority, and that representations to the contrary would be a criminal offense.
Corporate status and structure
Globalink is identified in its filings as an emerging growth company and as a shell company focused on completing an initial business combination rather than conducting an operating business. The company’s securities registered under Section 12(b) of the Securities Exchange Act are described in one filing as “None,” indicating that at the time of that filing, it did not have securities listed on a national securities exchange under that section. Its operations, as described in the filings, center on corporate and transactional activities related to the proposed business combination and the management of its trust account.
Because Globalink operates as a SPAC, its long-term identity and business profile are expected to be defined by the outcome of its business combination with Alps and the subsequent role of PubCo as the surviving publicly traded entity. The filings provide detailed descriptions of the transaction structure, the roles of the various parties, and the processes by which stockholders can vote on and, where applicable, redeem their shares in connection with the transaction.
FAQs about Globalink Investment Inc. (GLLI)
Similar Stocks
See how related companies performed
Frequently Asked Questions
Globalink Invest investment returns
How much would $1,000 invested in Globalink Invest be worth today?
If you invested $1,000 in Globalink Invest (GLLI) 1 years ago on 2025-07-09, your investment would be worth $255 today, representing a -74.5% total return, growing at a compounded rate of -98.8% per year (CAGR).
Has Globalink Invest outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare GLLI performance over available time periods.
What is Globalink Invest's average annual return?
The compound annual growth rate (CAGR) of GLLI over the past 1 years is -98.8%, growing at a compounded rate each year. Individual years vary significantly — GLLI's best recent year was 2024 (+8.5%) and worst was 2025 (-74.5%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.